AVAXATAP, created in 2008 (United States), from 496 sister brands and 17477 competing brands. The AVAXATAP brand is owned by BRISTOL-MYERS SQUIBB COMPANY, a company listed in New York. AVAXATAP is part of the Drug Manufacturers activity sector.
Investment simulator :
Portfolio valuation
BRISTOL-MYERS SQUIBB COMPANY
(AVAXATAP)
over 5 years*
USD 43.24